Roadmap for health and well-being in Central Asia (2022–2025)
Overview
In 2022, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan and Uzbekistan adopted the WHO Roadmap for Health and Well-being in Central Asia 2022–2025 – the first roadmap of its kind in the central Asian subregion. It serves as the foundation to “deliver as one” on resource mobilization and investment opportunities for health. The aim is clear: health is an essential driver of central Asia’s socioeconomic development.
The Roadmap builds on the individual health goals and priorities of central Asian countries while also applying the lens of the WHO European Programme of Work, 2020–2025 – “United Action for Better Health”, embedding it in the broader regional context. To contribute to an inclusive and sustainable future for people across the subregion, the Roadmap identifies 11 high-impact action areas and 32 reform initiatives.
Action areas
These high-impact action areas comprise:
WHO/Europe, the 5 countries and other partners implement the Roadmap together, facilitated by a high-level standing group. The Roadmap provides an innovative, strategic and customized framework that promotes country-level health goals and priorities, and targets investment into critical areas of health systems across this subregion. In 2023, the Roadmap received support from the highest political level, when it was endorsed by the presidents of Kazakhstan, Kyrgyzstan, Tajikistan and Uzbekistan, and included in the Outcome Document of the 5th Consultative Meeting of the Heads of State of Central Asia, held on 14 September 2023 in Dushanbe, Tajikistan. The Central Asia International Health Investment Forum, on 26–27 June 2024 in Bishkek, Kyrgyzstan, organized by WHO/Europe and the Ministry of Health of Kyrgyzstan is a further opportunity to increase investment in health and accelerate progress to achieve the Sustainable Development Agenda by 2030.
